Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting Stent Trial

NCT01035450 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

3206

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: Everolimus-eluting stent
DEVICE: Sirolimus-eluting stent

Sponsor

Takeshi Morimoto